Madrigal Pharmaceuticals, Inc.
MDGL· Nasdaq
Released Nov 4, 2013, before the open
10-Q filed Nov 4, 2013, 35 days after period end · 0001104659-13-080239
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| EPS Diluted | -$0.33 | -$0.25 | -$0.26 | -$0.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Madrigal Pharmaceuticals, Inc. · CIK 1157601 · Engraved from SEC EDGAR
ended Sep 30, 2013 · filed Nov 4, 2013 · 35 d after period end